Literature DB >> 21215378

Third INTERMACS Annual Report: the evolution of destination therapy in the United States.

James K Kirklin1, David C Naftel, Robert L Kormos, Lynne W Stevenson, Francis D Pagani, Marissa A Miller, Karen L Ulisney, J Timothy Baldwin, James B Young.   

Abstract

The third annual report of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) provides documentation of the current landscape of durable mechanical circulatory support in the United States. With nearly 3,000 patients entered into the database, the transition to continuous-flow pump technology is evident and dramatic. This report focuses on the rapidly expanding experience with mechanical circulatory support as destination therapy. The current 1-year survival of 75% with continuous-flow destination therapy provides a benchmark for the evolving application of this therapy.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2011        PMID： 21215378     DOI： 10.1016/j.healun.2010.12.001

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN： 1053-2498            Impact factor:   10.247


  65 in total

Review 1.  Mechanical circulatory support for elderly heart failure patients.

Authors:  Craig R Butler; Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Early decision for a left ventricular assist device implantation is necessary for patients with modifier A.

Authors:  Teruhiko Imamura; Koichiro Kinugawa; Taro Shiga; Miyoko Endo; Toshiro Inaba; Hisataka Maki; Masaru Hatano; Yasushi Imai; Atsushi Yao; Yasunobu Hirata; Takashi Nishimura; Shunei Kyo; Minoru Ono; Ryozo Nagai
Journal:  J Artif Organs       Date:  2012-04-18       Impact factor: 1.731

3.  The rise of cardiovascular medicine.

Authors:  Eugene Braunwald
Journal:  Eur Heart J       Date:  2012-03-12       Impact factor: 29.983

Review 4.  Is myocardial recovery possible and how do you measure it?

Authors:  Douglas L Mann; Daniel Burkhoff
Journal:  Curr Cardiol Rep       Date:  2012-06       Impact factor: 2.931

5.  Ventricular assist devices: initial orientation.

Authors:  Martin Schweiger; Hitendu Dave; Frithjof Lemme; Olga Romanchenko; Michael Hofmann; Michael Hübler
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

Review 6.  Ventricular assist devices: pharmacological aspects of a mechanical therapy.

Authors:  O Wever-Pinzon; J Stehlik; A G Kfoury; J V Terrovitis; N A Diakos; C Charitos; D Y Li; S G Drakos
Journal:  Pharmacol Ther       Date:  2012-01-16       Impact factor: 12.310

7.  The future of adult cardiac assist devices: novel systems and mechanical circulatory support strategies.

Authors:  Carlo R Bartoli; Robert D Dowling
Journal:  Cardiol Clin       Date:  2011-11       Impact factor: 2.213

8.  Predictors of hospital length of stay after implantation of a left ventricular assist device: an analysis of the INTERMACS registry.

Authors:  William G Cotts; Edwin C McGee; Susan L Myers; David C Naftel; James B Young; James K Kirklin; Kathleen L Grady
Journal:  J Heart Lung Transplant       Date:  2014-03-01       Impact factor: 10.247

9.  Paracorporeal ventricular assist device as a bridge to transplant candidacy in the era of implantable continuous-flow ventricular assist device.

Authors:  Hideaki Suwa; Osamu Seguchi; Tomoyuki Fujita; Yoshihiro Murata; Michinari Hieda; Takuya Watanabe; Takuma Sato; Haruki Sunami; Masanobu Yanase; Hiroki Hata; Takeshi Nakatani
Journal:  J Artif Organs       Date:  2013-10-06       Impact factor: 1.731

Review 10.  Heart transplantation and end-stage cardiac amyloidosis: a review and approach to evaluation and management.

Authors:  Jerry D Estep; Arvind Bhimaraj; A M Cordero-Reyes; Brian Bruckner; Matthias Loebe; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2012 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.